Drug · DIN 02565951
BILDYOS
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 19, 2026; first marketed May 19, 2026.
- Drug Identification Number (DIN)
- 02565951
- Company (DIN owner)
- Shanghai Henlius Biotech, Inc.Shanghai, China
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Denosumab M05BX04
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENOSUMAB | 60 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 9, 2026: NOC 37095New Drug Submission (NDS)
Other DINs named BILDYOS
- DIN 02565943 · Approved